Although blocking the Programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PDL-1) Axis led to a paradigm shift in cancer immunotherapy and showed great potential in cancer treatment, it cannot be generalized to all types of cancers3,4. The gene discussed is CD274; the disease is cancer.